We proved for the first time that EFEMP2 could bind to EGFR to activate ERK1/2/c-Jun pathway and regulate PD-L1 expression (Fig. 9I), furthermore, PD-L1 was extremely important for EFEMP2 to promote ovarian cancer cells invasion in vitro and in vivo. Here, MAPK3 is linked to ovarian carcinoma.